>
Lucid Is Working On A Tesla Cybercab Competitor. See The Futuristic Two-Seat Taxi Here
New AI Farm Robots Can Identify Weeds and Kill Them, Eliminating the Need for Toxic Herbicides
US-Israel Iran War Live Updates: Iran vows to make Trump sorry for 'grave miscalculation';
COL. Douglas Macgregor : Is Washington Overplaying Its Hand? :
Human Brain Cells Merge With Silica To Play DOOM
Will Yann LeCun Provide The Next Breakthrough In AI?
Human Brain Cells Merge With Silica To Play DOOM
Solar And Storage Could Reshape Rural Electricity Markets
With World Seemingly At War, DARPA Finds Time To Unveil The X-76
The world's first diesel plug-in hybrid pickup truck is here
US advances nuclear revival with approval of Natrium Gen IV reactor
Your Contractor Doesn't Want Me To Show You This!
CEO of Blacklisted AI Company Anthropic, Dario Amodei Says His AI Models 'May Have Gained...

The Oxford-AstraZeneca coronavirus vaccine will be withdrawn worldwide just months after the firm admitted that the jab causes a rare but dangerous side effect, however, AstraZeneca insists that the decision to pull the vaccine was purely made for commercial reasons.
AstraZeneca pulled its "marketing authorisation" for its COVID-19 vaccine, known commercially as Vaxzevria, in the European Union on Tuesday and plans to do so in the UK and other countries where it was deployed in the coming months. The decision will not impact the United States, where the jab never received approval to go to market.
The pharmaceutical giant insisted that the decision was made for commercial considerations, saying that the vaccine is no longer being manufactured and that more recent vaccines have been developed to confront novel variants of the Chinese virus.